After more than 30 years in the hydroponics business and years of working with medical cannabis patients at Paradise Compassion Club, one thing has become very clear to me: people aren’t all looking for the same thing. Some want relief from chronic pain. Others are dealing with nausea, muscle spasms, or symptoms that make ordinary days difficult. What interests me most is that modern medical research is increasingly taking these experiences seriously.
I wanted to put together an article that focuses on the positive side of medical cannabis: where it has demonstrated benefits, where the evidence is encouraging, and why patients continue to ask questions about it. Cannabis isn’t one medicine with one effect. Different products contain different cannabinoids, including THC and CBD, and their effects depend on the formulation, dose, and condition being treated.
Chronic pain: one of the biggest reasons patients turn to cannabis
Chronic pain can interfere with sleep, movement, work and just about every part of daily life. For some patients, cannabis-based medicines provide modest but meaningful pain relief. A major 2025 randomized Phase 3 trial of an investigational cannabis extract for chronic low-back pain enrolled 820 people and found better pain outcomes than placebo. More participants taking the extract achieved at least a 30% reduction in pain. That’s encouraging because it comes from a controlled trial rather than testimonials alone.
The improvement wasn’t dramatic for everybody, and the trial studied a specific standardized extract—not every strain or product sold as cannabis. Still, it adds to a growing body of evidence that certain cannabis-based medicines can help some people living with persistent pain.
Helping patients through chemotherapy-related nausea and vomiting
One of the longest-established medical uses of cannabinoids is helping control nausea and vomiting caused by cancer chemotherapy. Prescription cannabinoid medicines such as dronabinol and nabilone have been used for this purpose, particularly when standard anti-nausea treatments haven’t provided enough relief.
For someone already going through cancer treatment, being able to keep food down and feel less sick can make an enormous difference in day-to-day comfort. This is an area where cannabinoid medicine has a real clinical history, not just an emerging theory.
Multiple sclerosis and painful muscle spasticity
People living with multiple sclerosis can experience painful muscle stiffness, spasms and interrupted sleep. Research has found that certain cannabinoid preparations can reduce patient-reported spasticity symptoms for some people with MS. A standardized THC/CBD mouth spray, known as nabiximols or Sativex, has been used in several countries, including Canada, for selected MS-related symptoms.
The benefit is especially important to consider from the patient’s perspective. Even when a clinical examination doesn’t capture a large change, someone may experience fewer troublesome spasms or feel more comfortable getting through the day.
CBD and certain severe seizure disorders
One of the clearest examples of a cannabinoid becoming an evidence-based medicine is purified cannabidiol, or CBD. Randomized trials have demonstrated that prescription-grade CBD can reduce seizure frequency in specific severe epilepsy syndromes, including Dravet syndrome, Lennox–Gastaut syndrome and tuberous sclerosis complex.
This research matters because it shows how a compound found in cannabis can be studied, standardized and used for particular medical conditions. It doesn’t mean that ordinary CBD oil or cannabis flower has been proven to treat every type of epilepsy; the evidence is tied to specific pharmaceutical formulations and carefully managed treatment.
Sleep and quality of life when symptoms improve
Anyone dealing with persistent pain or spasms knows that a difficult night can make the following day harder. In some medical cannabis studies, patients report improvements in sleep or quality-of-life measures alongside improvements in their primary symptoms. For me, that broader picture matters. If someone experiences less discomfort at night and functions better during the day, that’s a meaningful outcome worth investigating.
We still need more well-designed studies to determine which products help which sleep problems most reliably. But the connection between symptom relief, rest and everyday quality of life deserves attention.
Appetite and weight loss associated with serious illness
Prescription THC-based medicines have also been used to stimulate appetite in people experiencing significant appetite loss, including patients with HIV/AIDS-related anorexia. For people struggling to eat enough, appetite is not a small concern. Maintaining nutrition can be part of maintaining strength and quality of life.
This is another example of why medical cannabis shouldn’t be discussed as though every patient has the same goal. Pain relief, seizure reduction and appetite support are different medical needs, and the research behind each is different.
Why I believe patient experience and research both matter
At Paradise Compassion Club, we’ve always believed in listening to patients. Their experiences can point researchers toward questions worth studying. At the same time, controlled clinical trials help us separate promising possibilities from benefits that have actually been demonstrated.
What encourages me is that the conversation has moved beyond simply asking whether cannabis has any medical value. For several specific conditions and symptoms, the answer is already yes: particular cannabis-derived or cannabinoid medicines have demonstrated benefits. The next challenge is learning which formulations work best, who benefits most, and how to make treatment more consistent and accessible.
Patients should discuss medical cannabis with a knowledgeable healthcare professional, especially if they use prescription medications. The goal is to make informed choices and add useful options to patient care.
Looking ahead
I’ve spent a lot of my life around plants, growing equipment and people who care deeply about the quality of what they produce. What keeps me interested in medical cannabis isn’t just the cultivation. It’s the possibility of helping people live more comfortably.
We have more clinical evidence today than we did years ago, and there is still plenty left to learn. To me, that’s a reason for optimism. Good research, good cultivation and a patient-first attitude can all be part of moving medical cannabis forward.
Research and further reading
- 2025 randomized Phase 3 trial of a cannabis extract for chronic low-back pain, Nature Medicine
- US National Center for Complementary and Integrative Health: Cannabis and cannabinoids—medical evidence overview
- US National Cancer Institute: Cannabis and cannabinoids (health professional evidence summary)
- US FDA: Cannabis-derived medicines and approved CBD treatment information
Paradise Compassion Club
Quality • Care • Community